Abstract Earlier studies have reported an increase in the proximal tubule AT 2 receptor (AT 2 R) expression in diabetes, with a beneficial role in kidney function and blood pressure regulation. Here, we demonstrate that the increase in AT 2 R protein expression is associated with an increased expression of transcription factor IRF-1 in hyperglycemic rat and in high glucose-treated HK2 cells. Knock-down of IRF-1 by siRNA in HK2 cells prevented high glucoseinduced AT 2 R up-regulation. The data suggest that IRF-1 is a transcriptional regulator of AT 2 R expression in hyperglycemia, and warrant further studies to understand the physiological role of IRF-1 along with AT 2 R in diabetic kidney.
Introduction
Angiotensin II (Ang II) is major effector of renin angiotensin system and mediates its cellular and physiological actions by acting on AT 1 and AT 2 receptor (AT 2 R) subtypes [1] . Most of the cellular and physiological actions of Ang II such as cellular growth, proliferation, vasoconstriction, antinatriuresis, and increase in blood pressure are mediated via AT 1 receptor [1] . The functions associated with the AT 2 Rs are less studied, in part, due to its lower expression in adult tissues [1] . However, AT 2 R has been suggested as a functional antagonist of AT 1 receptors and thereby opposes the actions of Ang II mediated via AT 1 receptor [2, 3] . Thus, the activation of AT 2 Rs has been shown to cause vasodilatation, natriuresis, and decrease in blood pressure [3] . The signaling pathways that mediate AT 2 Rs functions, include NO/cGMP generation, activation of phosphatases and p38 MAP kinase pathways [3] [4] [5] .
The AT 2 R expression is abundant in fetus but regresses after birth [1, 6] . The expression of AT 2 R is regulated via transcription factors of IRF-1 and CEB/Pb in response to gluco-corticoids and growth factors [6] [7] [8] . Recently, increase in the AT 2 R expression in adult animal tissues, especially in the kidney has been reported in certain pathophysiological conditions such as diabetes and renal injury [9] [10] [11] [12] . The enhanced expression of AT 2 Rs in the proximal tubules of obese Zucker rats [4] and streptozotocin-treated diabetic rats [5] has a direct role in natriuresis and diuresis. This function of AT 2 R on renal sodium excretion may be protective against blood pressure increase in hyperglycemic obese Zucker rats [13] . Hyperglycemia or high glucose concentration has been reported to stimulate various proinflammatory genes, including various transcription factors contributing to tissue damage [14] [15] [16] . While we have reported an increase in AT 2 R expression in the proximal tubules of obese and other diabetic rat models [4, 5] , causeeffect relationship between high glucose and AT 2 R expression and the molecular mechanisms responsible for this association is not known. Therefore, we utilized HK2 cells, a proximal tubule epithelial cell line derived from human kidney, which express AT 2 R (able to inhibit Na ? , K ? -ATPase, unpublished data) for testing our hypothesis that high glucose regulates AT 2 R expression via interferon regulatory factor-1 (IRF-1). We found that high glucose increases AT 2 R expression, and that IRF-1 knockdown by siRNA abolished the effect of high glucose on the AT 2 R expression.
Materials and methods

Chemicals
Human kidney proximal tubule epithelial (HK2) cells were purchased from ATCC (Chicago, IL). Keratinocyte-serum free media (K-SFM) and fetal bovine serum (FBS) were purchased from Invitrogen Corporation, NY. siRNA IRF-1 (h), control siRNA, siRNA transfection reagent containing lipofectamine, polyclonal antibodies for IRF-1, IRF-2, and monoclonal antibody for b-actin were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Polyclonal AT 2 R antibody was purchased from either Alpha Diagnostics Intl (San Antonio, TX) or Santa Cruz Biotechnology (Santa Cruz, CA). HRP-coupled anti-IgG and enhanced chemiluminescence substrates were obtained from Alpha Diagnostics Intl (San Antonio, TX). Other chemicals used in the study were purchased from SigmaAldrich (St. Louis, MO).
Cell culture HK2 cells were cultured using K-SFM supplemented with 5% FBS, epidermal growth factor (EGF) and bovine pituitary extract (BPE). The cells used in the experiment were between passages 4-12. Cells were seeded at 1 9 10 6 in 100 9 20 mm culture dish.
Treatment with glucose
At 50-60% confluency, the HK2 cells were treated with normal (5 mM) and high glucose (25 mM) for 24 h. In another set of experiments, the cells also were treated with equimolar glucose ? sorbitol (20 mM sorbitol ? 5 mM glucose) to examine the role of hyperosmolarity per se on AT 2 R expression. After treatment with glucose or sorbitol, the cell were lysed and processed for western blotting as described in ''Western blotting'' section.
siRNA transfection of HK2 cells
The transfection of HK2 cells with siRNA IRF-1 (CUCCA CCUCUGAAGCUACATT), which was a pool of three different siRNA duplexes with mRNA location on position 851, 854, and 1652 downstream of the IRF-1 gene. There are several IRF-1 binding motifs present in the upstream of the promoter in positions between -453 and -225 of the AT 2 R gene. Briefly, the cells at 50-60% confluency were incubated with serum free medium for 3-4 h before transfection. Thereafter, the transfection was performed using lipofectamine as transfecting reagent. The cells were incubated with the siRNA IRF-1 at different concentrations (0.01-0.1 lM). After 6 h of incubation, the existing media was replaced with a fresh media and the cells were incubated for additional 24 and 48 h. The significant knockdown of IRF-1 was achieved at 0.1 lM siRNA at 48 h and this regimen was used in subsequent experiments for testing the effect of glucose on AT 2 R expression. After siRNA transfection (0.1 lM, 48 h), the cells were incubated with normal and high glucose for 24 h. Cells treated with transfecting reagent alone served as control, which were also incubated with normal and high glucose. Also, we used control siRNA (Santa Cruz, CA Cat # 37007) with scrambled sequence, which does not interfere with any known cellular mRNA.
Proximal tubules from lean and obese Zucker rats
Male obese and lean Zucker rats (12 weeks of age) were purchased from Harlan, Indianapolis; IN. The rats were housed in the University of Houston animal care facility. Food and water were supplied ad libitum during this period.
The rats were anaesthetized with inactin (100 mg/kg body wt). After midline incision, kidneys were selectively infused with Krebs buffer containing collagenase and hyaluronidase. Kidney cortices were dissected and used to prepare proximal tubule suspension by the percoll densitygradient centrifugation method [4, 5] . Proteins in the proximal tubules were determined by BCA method using a kit (Pierce, Rockford, IL).
Western blotting
The HK2 cells were washed with cold phosphate buffered saline and lysed in 0.3 ml of lysis buffer containing 0.5 M Tris base (pH 6.8), 1% SDS, 1 mM EDTA, 1 mM PMSF, and protease inhibitor (aprotinin, calpain inhibitors, leupeptin, pepstatin, and trypsin inhibitor). The cell lysates were used for protein estimation by BCA method using a kit. Equal amounts (60 lg for AT 2 , IRF-1 and IRF-2) of proteins from HK2 cells were subjected to SDS-PAGE and transferred onto immobilon P (blot). Similarly, proteins in proximal tubules from lean and obese Zucker rats were determined and 60 lg of the protein samples were subjected to western blotting for AT 2 R, IRF-1 and IRF-2 using respective protein specific polyclonal antibodies. Polyclonal IgG-linked with horseradish peroxidase and the ECL system were used to detect the signal, which were analyzed by FluorChem 8800 (Alpha Innotech Imaging System, San Leandro, CA). b-actin was used as a loading control.
In a separate set of experiments, we have determined the specificity of the AT 2 R antibody in Sprague-Dawley rat kidneys selectively treated with AT2 siRNA for 5, 7, and 14 days. The AT2 antibody was able to detect changes at various levels of AT 2 R expression at different days of siRNA treatment. The changes in AT 2 R protein expression were in parallel to the changes in AT2 mRNA expression (unpublished data). This test supports the validity of the AT 2 R measurement by either of the methods, i.e., western blotting or qRT-PCR.
qRT-PCR
Quantitative PCR (qRT-PCR) was performed both in HK2 cells and in rat proximal tubules by using the SYBR Green detection method. After treating HK2 cells with normal and high glucose, RNA was isolated by RNeasy mini kit (Qiagen, Valencia, CA). The RNA (50 ng) isolated from HK2 cells was used for making cDNA by using Advantage RT-PCR kit (Clonetech Mountain View, CA). The resulting cDNA was used for measuring AT 2 R by RT-PCR machine (Applied Biosystem 7300). The primer used for amplification of AT 2 0 . Two different primers were designed based on human and rat genes to ensure the primers' specificity in respective source of samples, i.e., human derived HK2 cells and rat proximal tubules.
Statistical analysis
Results are expressed as the mean ± SEM. The data were subjected to statistical analysis (Student's t test) and oneway ANOVA followed by Newman-Keuls test using GraphPad Prism 4, San Diego, CA. Values at P \ 0.05 were considered to be statistical significant. (Figs. 1aA, 4) . Sorbitol (20 ? 5 mM glucose) treatment of HK2 cells for 24 h had no significant effect on AT 2 R expression (Fig. 1aC) suggesting that AT2 protein expression change during high glucose incubation was not due to hyper-osmolarity of the medium. Similarly, densitometric analysis revealed that the expression of IRF-1 as well as of AT 2 R in the proximal tubules was significantly elevated in obese compared with lean Zucker rats (Fig. 1bA, bC) .
Results
AT
The qRT-PCR analysis also revealed a significant increase in AT 2 mRNA levels in both the high glucosetreated cells as compared to control HK2 cells (Fig. 1aB) and the proximal tubules of obese Zucker rats as compared to their lean controls (Fig. 1bB) .
Effect of IRF-1 knockdown on glucose-induced up-regulation of AT 2 R
To study the role of IRF-1 in high glucose-induced AT 2 R up-regulation, we optimized the conditions to knock-down IRF-1 using IRF-1 siRNA (10 and 100 nM) for 24 and 48 h (Fig. 2) . Treatment with siRNA (100 nM) for 48 h down regulated IRF-1 protein expression by 50% in HK2 cells. IRF-1 siRNA did not affect the expression of IRF-2, suggesting the specificity of the siRNA (Fig. 3) . The reduction in IRF-1 expression was associated with the reduction in AT 2 expression in HK2 cells. However, incubation of 100 nM siRNA-treated cells with high glucose restored the expression of both the IRF-1 and the AT 2 Rs (Fig. 3) . In another set of experiments, we used higher siRNA concentration (500 nM) in order to prevent the effect of high glucose on IRF-1 expression. Higher siRNA concentration was able to maintain lower IRF-1 expression even in the presence of high glucose. This lowering of IRF-1 expression abolished glucose-induced AT 2 R up-regulation (Fig. 4) . The data clearly suggest that glucose induces an IRF-1 dependent upregulation of AT 2 R.
Discussion
This study directly demonstrates that high glucose induces AT 2 R expression in the proximal tubule epithelial cells and this process is mediated via an increase in the transcription factor IRF-1 expression.
Earlier, we have reported AT 2 R expression increase in the proximal tubules of obese Zucker rats and streptozotocin-induced diabetic rats [4, 5] . The AT 2 R upregulation potentially promotes renal sodium excretion and protects against blood pressure increase in these animals [4] . The incubation of HK2 cells with high glucose concentration suggests that glucose has a positive regulatory role in AT 2 R expression. Hyperglycemia is known to activate various stress kinases leading to hypertrophy and tissue damage, including kidney damage [17] . The increase in AT 2 R expression in response to high glucose could be a compensatory mechanism to improve kidney function and to prevent blood pressure increase in diabetic animals. In pursuit of understanding the mechanism of glucoseinduced AT 2 R expression, we found that the increase in AT 2 R mRNA was associated with the increase in AT 2 R protein, and increase in IRF-1 expression in the proximal tubules of obese Zucker rats. These findings suggest a potential association between the increases in AT 2 and IRF-1, the notion supported by the IRF-1 knock-down studies. However, high glucose reverted the knock-down of IRF-1 expression by siRNA (100 nM). The reversal in IRF-1 expression was associated with simultaneous reversal in the reduction of AT 2 R expression. This suggested that high Values are represented as mean ± SEM, * significantly different from control HK2 cells (one-way ANOVA followed by Neuman-Keuls test, P \ 0.05, n = 3). CT control, HG high glucose, SS scrambled sequence the presence of high glucose, we used higher concentration of siRNA (500 nM). With this strategy, we were able to keep the low expression of IRF-1, and high glucose was unable to increase AT 2 R expression, suggesting a role of IRF-1.
How does glucose regulates IRF-1 expression is not clear. However, p38 pathway may be a plausible mechanism responsible for high glucose-induced IRF-1 up-regulation/activation leading to AT 2 R transcription. Activation of p38 has been implicated in the cellular response to hyperglycemia. High levels of glucose stimulate p38 in proximal tubular cells and other kidney cells such as mesangial cells [18] . Also, enhanced p38 activation is reported in the proximal tubules of obese Zucker rats [19] . Moreover, the activated p38 pathway causes activation of a number of transcription factors, including IRF-1 [20] [21] [22] [23] [24] [25] . Since IRF-1 regulates AT 2 R transcription, it might be possible that glucose-induced AT 2 R up-regulation involves IRF-1 via p38 pathway. Glucose also is known to stimulate various inflammatory signals leading to tissue injury, including kidney [17] . For example, high glucose concentrations activate tumor necrosis factor-a (TNF-a) and migration inhibitory factor (MIF) which leads to phosphorylation of ERK1/2 pathway [18, 26] . The increase in AT 2 R expression in response to high glucose appears to be beneficial, in terms of renal function and protection against blood pressure increase [13] . However, it is not clear whether increase in the IRF-1 expression in response to hyperglycemia has other cellular and physiological consequences. IRF-1 is known to act as a transcriptional activator and is regulated by different cytokines such as IFN-a, IFN-b and mediates cell growth, transformation, and apoptosis [25, 27] . IRF-1 is dramatically upregulated in certain patho-physiological conditions [27] . If increase in the IRF-1 expression and hence in AT 2 R expression and function are beneficial to the diabetic kidney and blood pressure control, these molecules provide novel targets to treat kidney disease and hypertension. Studies for understanding the role of selective activation of AT 2 R in long-term blood pressure control are underway.
In summary, we found that the expression of AT 2 R and IRF-1 is increased in proximal tubules of obese Zucker rats and in HK2 cells treated with high concentration of glucose. The siRNA knock-down studies suggest that glucose is a potent stimulator of IRF-1 expression, which mediates increase in AT 2 R expression in response to high glucose. While there is reasonable physiological relevance of AT 2 R, the role of IRF-1 in renal physiology and blood pressure control needs to be investigated.
